Autonomic Dysreflexia Clinical Trials

Find Autonomic Dysreflexia Clinical Trials Near You

Assessment of Cardiac Morphology and Function in Individuals With and Without Autonomic Dysreflexia Due to Spinal Cord Injury or Disease

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This case-control study aims to investigate left ventricular remodeling in individuals with chronic spinal cord injury or disease (SCI/D) (≥10 years) and autonomic dysreflexia (AD) who have no prior cardiovascular history. The primary objective is to compare cardiac changes between 24 individuals with high-level SCI/D (above Th6) who have AD and 24 individuals with low-level SCI/D (below Th10) who do not have AD. A secondary objective examines how factors such as age, sex, injury duration, and physical activity are associated with cardiac remodeling. All 48 participants will undergo cardiac MRI as well as blood measurement of B-type natriuretic peptid to assess cardiac morphology and function. The findings could shed light on a potentially underestimated cardiovascular risk factor in the SCI/D population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• adults aged 18 years or older

• long-term (\>10 years), motor-complete SCI/D (AIS A and B)

• Group A (24 individuals): high-level (\>Th6) SCI/D and autonomic dysreflexia

• Group B (24 individuals): low-level (\<Th10) SCI/D without autonomic dysreflexia

• signed informed consent

Locations
Other Locations
Switzerland
Swiss Paraplegic Center
RECRUITING
Nottwil
Contact Information
Primary
Jörg Krebs, PD Dr. med. vet. PhD
joerg.krebs@paraplegie.ch
+41 41 939 5946
Backup
Florian van Dellen, Dr. sc.
florian.vandellen@paraplegie.ch
+41 41 939 6542
Time Frame
Start Date: 2026-06-01
Estimated Completion Date: 2028-10-31
Participants
Target number of participants: 48
Treatments
AD+
Spinal Cord Injury, above Th6, AIS A or B, Autonomic Dysreflexia
AD-
Spinal Cord Injury, below Th10, AIS A or B, no Autonomic Dysreflexia
Related Therapeutic Areas
Sponsors
Leads: Swiss Paraplegic Research, Nottwil

This content was sourced from clinicaltrials.gov